Ozempic is FDA approved for use in adults with type 2 diabetes to help: manage blood sugar levels, along with a healthy diet and exercise reduce the risk of major cardiovascular (heart or blood vessel) problems in people who also have cardiovascular disease reduce the risk of worsening kidney disease and death from cardiovascular disease in people who also have chronic kidney disease There has been increasing interest in using Ozempic for weight loss, but there is currently not enough evidence to support the safe and effective use of Ozempic for weight loss
research compound only Main studied indication / GH-IGF axis deficiencies
Many people will be able to switch to generic semaglutide
- - - A new 2-year comparative study from NYU Langone just droppedand the results are clear: Bariatric Surgery vs GLP-1s (semaglutide/tirzepatide): 25.7% total body weight loss with surgery vs 5.3% with GLP-1s (intention-to-treat) Even in per-protocol analysis (continuous GLP-1 use), surgery still outperformed: 24.6% vs 7.6% Surgery had better HbA1c improvement, too Translational Insight: Yes, the relatively low weight loss in the medication group was partly due to therapy interruptions and discontinuation
They may repeat sessions throughout the first few weeks of recovery
Abstract Background Melatonin (MT) and selenium (Se) are quite known in application in regulation of abiotic stress tolerance where metals remain important